David Shaw’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$104K Buy
+11,400
New +$126K ﹤0.01% 4637
2026
Q1
Sell
-10,550
Closed -$160K 4902
2025
Q4
$160K Sell
10,550
-6,932
-40% -$106K ﹤0.01% 4360
2025
Q3
$256K Sell
17,482
-72,851
-81% -$956K ﹤0.01% 4188
2025
Q2
$1.01M Buy
90,333
+37,953
+72% +$470K ﹤0.01% 3229
2025
Q1
$854K Buy
52,380
+6,221
+13% +$109K ﹤0.01% 3188
2024
Q4
$806K Sell
46,159
-259
-0.6% -$4.5K ﹤0.01% 3336
2024
Q3
$725K Buy
46,418
+23,981
+107% +$384K ﹤0.01% 3489
2024
Q2
$298K Buy
+22,437
New +$307K ﹤0.01% 3897
2023
Q4
Sell
-14,464
Closed -$186K 4517
2023
Q3
$186K Sell
14,464
-6,346
-30% -$114K ﹤0.01% 3781
2023
Q2
$376K Sell
20,810
-54,506
-72% -$1.02M ﹤0.01% 3528
2023
Q1
$1.26M Sell
75,316
-137,130
-65% -$2.68M ﹤0.01% 3005
2022
Q4
$4.36M Buy
212,446
+146,131
+220% +$2.58M ﹤0.01% 2224
2022
Q3
$1.27M Buy
66,315
+14,713
+29% +$331K ﹤0.01% 3411
2022
Q2
$1.22M Sell
51,602
-1,094
-2% -$31.3K ﹤0.01% 3496
2022
Q1
$1.72M Sell
52,696
-11,074
-17% -$356K ﹤0.01% 3446
2021
Q4
$1.98M Buy
63,770
+7,326
+13% +$245K ﹤0.01% 3374
2021
Q3
$2.15M Sell
56,444
-4,772
-8% -$190K ﹤0.01% 2971
2021
Q2
$2.46M Buy
61,216
+11,833
+24% +$500K ﹤0.01% 2737
2021
Q1
$2.14M Sell
49,383
-15,090
-23% -$665K ﹤0.01% 2530
2020
Q4
$2.77M Sell
64,473
-30,357
-32% -$1.11M ﹤0.01% 2330
2020
Q3
$2.95M Sell
94,830
-9,605
-9% -$298K ﹤0.01% 2086
2020
Q2
$3.34M Sell
104,435
-34,433
-25% -$1.14M ﹤0.01% 1991
2020
Q1
$3.89M Buy
138,868
+1,421
+1% +$55K 0.01% 1652
2019
Q4
$6.35M Buy
137,447
+53,136
+63% +$2.5M 0.01% 1543
2019
Q3
$4.47M Buy
84,311
+24,936
+42% +$1.29M 0.01% 1731
2019
Q2
$3.14M Buy
59,375
+39,542
+199% +$2.1M ﹤0.01% 1932
2019
Q1
$1.12M Buy
19,833
+1,562
+9% +$87.7K ﹤0.01% 2541
2018
Q4
$959K Sell
18,271
-454
-2% -$25.8K ﹤0.01% 2694
2018
Q3
$1.08M Sell
18,725
-22,034
-54% -$1.23M ﹤0.01% 2653
2018
Q2
$2.32M Sell
40,759
-18,147
-31% -$1.03M ﹤0.01% 2121
2018
Q1
$3.46M Buy
58,906
+2,399
+4% +$134K ﹤0.01% 1664
2017
Q4
$3.09M Sell
56,507
-3,491
-6% -$181K ﹤0.01% 1827
2017
Q3
$2.83M Sell
59,998
-15,345
-20% -$723K ﹤0.01% 1780
2017
Q2
$3.5M Sell
75,343
-42,756
-36% -$1.77M 0.01% 1601
2017
Q1
$4.5M Sell
118,099
-148,494
-56% -$5.5M 0.01% 1360
2016
Q4
$9.65M Buy
266,593
+41,007
+18% +$1.56M 0.02% 958
2016
Q3
$9.65M Sell
225,586
-70,375
-24% -$3.14M 0.02% 910
2016
Q2
$12.5M Sell
295,961
-36,577
-11% -$1.59M 0.02% 769
2016
Q1
$13.8M Buy
332,538
+7,831
+2% +$307K 0.02% 693
2015
Q4
$12.7M Buy
324,707
+90,944
+39% +$3.4M 0.02% 853
2015
Q3
$7.89M Sell
233,763
-18,109
-7% -$645K 0.01% 1105
2015
Q2
$8.34M Sell
251,872
-16,843
-6% -$579K 0.01% 1124
2015
Q1
$9.64M Buy
268,715
+5,557
+2% +$175K 0.01% 984
2014
Q4
$7.91M Buy
263,158
+16,095
+7% +$472K 0.01% 1256
2014
Q3
$7.65M Sell
247,063
-90,578
-27% -$3.01M 0.01% 1263
2014
Q2
$12.2M Sell
337,641
-10,922
-3% -$353K 0.02% 969
2014
Q1
$10.5M Buy
348,563
+44,155
+15% +$1.02M 0.02% 1021
2013
Q4
$6.95M Buy
304,408
+50,550
+20% +$1.06M 0.01% 1418
2013
Q3
$5.29M Buy
253,858
+135,650
+115% +$3.29M 0.01% 1538
2013
Q2
$3.18M Buy
+118,208
New +$3.54M 0.01% 1693

Other funds holding OFIX

David Shaw's OFIX Position: Q2 2026 in Review

David Shaw opened a new position in Orthofix Medical (OFIX) in Q2 2026: 11,400 shares worth $104K. The stake represents ﹤0.01% of the portfolio and ranks #4637 among its holdings. This is a return to the name: David Shaw previously reported a position in OFIX as recently as Q4 2025.

David Shaw first reported a position in OFIX in Q2 2013 and has held it in 50 quarters since. The position peaked at $13.8M in Q1 2016. 142 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • David Shaw held 11,400 shares of Orthofix Medical worth $104K as of Q2 2026.
  • Orthofix Medical was a new David Shaw position in Q2 2026.
  • Orthofix Medical made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4637 holding.
  • David Shaw first reported a position in Orthofix Medical in Q2 2013 and has held it in 50 quarters since.
  • David Shaw's Orthofix Medical position peaked at $13.8M in Q1 2016.
  • 142 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.